rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2007-1-19
|
pubmed:abstractText |
To maximize sustained virologic response (SVR) in patients with chronic hepatitis C virus (HCV) infection, treatment with pegylated interferon and ribavirin has been genotype-specific (1 vs non-1). We evaluated the effects of ribavirin and peginterferon alfa-2a dose reductions on SVR in patients infected with HCV genotype 1.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1542-7714
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
124-9
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:17196435-Adult,
pubmed-meshheading:17196435-Antiviral Agents,
pubmed-meshheading:17196435-Clinical Trials, Phase III as Topic,
pubmed-meshheading:17196435-Dose-Response Relationship, Drug,
pubmed-meshheading:17196435-Drug Therapy, Combination,
pubmed-meshheading:17196435-Female,
pubmed-meshheading:17196435-Genotype,
pubmed-meshheading:17196435-Hepacivirus,
pubmed-meshheading:17196435-Hepatitis C, Chronic,
pubmed-meshheading:17196435-Humans,
pubmed-meshheading:17196435-Interferon-alpha,
pubmed-meshheading:17196435-Male,
pubmed-meshheading:17196435-Polyethylene Glycols,
pubmed-meshheading:17196435-RNA, Viral,
pubmed-meshheading:17196435-Randomized Controlled Trials as Topic,
pubmed-meshheading:17196435-Recombinant Proteins,
pubmed-meshheading:17196435-Retrospective Studies,
pubmed-meshheading:17196435-Ribavirin,
pubmed-meshheading:17196435-Treatment Outcome
|
pubmed:year |
2007
|
pubmed:articleTitle |
Impact of ribavirin dose reductions in hepatitis C virus genotype 1 patients completing peginterferon alfa-2a/ribavirin treatment.
|
pubmed:affiliation |
University of Pennsylvania, Philadelphia, Pennsylvania, USA. rajender.reddy@uphs.upenn.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|